Currently, more than 5 million Americans suffer from Alzheimer’s. This has profound implications for Arizona, with a population of more than 1 million people over age 65 living today that is expected to expand to 2.4 million by 2050.
At the Neurodegenerative Disease Research Center, we are aggressively pursuing new battleground tactics in the war against Alzheimer’s and other neurodegenerative diseases.
In addition to teasing out elusive genetic information, researchers are studying alterations in the brain sparked by environmental effects over time, asking how genes are modified or expressed – for better or worse? As epigenetic changes are known, they may point the way toward new treatment options.
A number of new hypotheses are being rigorously pursued in an effort to break the conceptual logjam. The Neurodegenerative Disease Research Center is pioneering new techniques of early detection, including blood biomarkers that will pinpoint neurodegenerative disease in its earliest phases, before it has irreparably ravaged the brain.
The center is a partnership between Banner Health and Arizona State University.